U.S. Transportation Stock News

In July 2026, a California Workers' Compensation Appeals Board judge sanctioned Lyft, Inc. a total of US$66,735 for willfully delaying discovery and repeatedly violating court orders to produce employment records in a catastrophic-injury case involving former driver Mark Nahvi, finding the company acted with malice. The ruling puts renewed focus on Lyft’s handling of worker-classification disputes in California, a long-running legal battleground for gig-economy employment models. Next, we’ll...

Immatics N.V. reported past second quarter 2026 results showing a net loss of €62.49 million, narrower than the prior year, while the six‑month net loss increased to €120.31 million. The company’s quarterly loss per share improved year on year, even as the cumulative loss for the first half of 2026 edged higher. Next, we will examine how Immatics’ narrower quarterly loss per share shapes its investment narrative in light of these mixed results. Uncover the next big thing with 22 elite penny...

U.S. Physical Therapy (USPH) has announced that Nchacha Etta will become Chief Financial Officer and Executive Vice President on September 1, 2026, a leadership change that could influence how investors view the stock. See our latest analysis for U.S. Physical Therapy. Over the past year, U.S. Physical Therapy has seen share price momentum pick up recently, with a 26.23% 3 month share price return contrasting with a 1 year total shareholder return that declined 8.24%. If this leadership...

We'd be surprised if SI-BONE, Inc. ( NASDAQ:SIBN ) shareholders haven't noticed that the CEO & Director, Laura Francis...

Earlier this month, Li Auto unveiled an updated Mega minivan that keeps its bullet-train silhouette while adding fully active suspension, a larger 108 kWh battery, dual motors with 554 hp, and an expected 441-mile CLTC range. This upgrade underlines Li Auto’s push to differentiate through high-end ride comfort and long-range battery tech in China’s premium EV segment. We’ll now examine how the fully active suspension upgrade in the Mega could influence Li Auto’s broader investment...

In August 2026, Immunome, Inc. reported second-quarter and six‑month results showing higher net losses and loss per share than the prior year. On the same day, the company filed a US$38.54 million shelf registration for 1,500,000 common shares tied to an employee stock ownership plan, highlighting its focus on future capital flexibility. Next, we’ll consider how the widened quarterly loss shapes Immunome’s broader investment narrative for investors assessing its long-term prospects. AI is...

Maplebear (CART), which operates Instacart, is back in focus after Academy Sports + Outdoors joined its Marketplace, adding same day delivery from more than 300 sporting goods stores across 21 states. See our latest analysis for Maplebear. The Academy Sports + Outdoors partnership arrives while Maplebear’s share price has risen 18.05% over the past 30 days and 20.89% over the past 90 days, with a 1 year total shareholder return of 14.90%, suggesting momentum is building from a relatively...

We'd be surprised if Bristow Group Inc. ( NYSE:VTOL ) shareholders haven't noticed that the Chief Operating Officer of...

Some Mercury Systems, Inc. ( NASDAQ:MRCY ) shareholders may be a little concerned to see that the President, William...

We wouldn't blame Medpace Holdings, Inc. ( NASDAQ:MEDP ) shareholders if they were a little worried about the fact that...

Anyone interested in Artesian Resources Corporation ( NASDAQ:ARTN.A ) should probably be aware that the Director, Dian...

In mid-August 2026, Synchrony Financial reported second-quarter results that exceeded expectations, raised its 2026 EPS outlook, appointed a Chief AI Officer, and detailed an enterprise-wide collaboration with OpenAI to embed advanced models into shopping, payments, and internal operations. Together, these moves suggest Synchrony is trying to reposition itself as an AI-forward consumer finance platform, using frontier models to rewire how it manages credit risk, develops products, and powers...

AECOM reported past third-quarter 2026 results showing sales of US$3,586.07 million and a net loss of US$86.71 million, alongside weaker year-to-date earnings versus the prior year. On the same day, the company cut its full-year 2026 outlook to factor in a Construction Management charge, delayed project starts, and disruption from Middle East conflict, even as underlying margins excluding these items were higher than expected. Next, we’ll examine how the Construction Management charge and...

Earlier this week, Regeneron Pharmaceuticals announced that the FDA approved Pasatru (garetosmab-grts), a monthly intravenous monoclonal antibody, to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with the ultra-rare disease fibrodysplasia ossificans progressiva. The approval is based on Phase 3 OPTIMA trial data showing Pasatru cut new abnormal bone lesions to just a few cases compared with many more on placebo, while also enabling administration...

Nuvation Bio (NUVB) stock is in focus after the U.S. FDA granted Fast Track Designation to safusidenib for IDH1-mutant glioma, following clinical data showing durable responses and a favorable risk-benefit profile. See our latest analysis for Nuvation Bio. At a latest share price of US$6.93, Nuvation Bio has seen a 46.82% 90 day share price return and a very large 3 year total shareholder return, although the year to date share price return is down 19.23%, which suggests momentum has picked...

Recent commentary on Par Pacific Holdings (PARR) highlighting its Zacks Rank #1 and value grade has put the stock in focus, as investors weigh its valuation metrics, earnings outlook and recent price performance. See our latest analysis for Par Pacific Holdings. Par Pacific Holdings has seen strong share price momentum over the past year, with a 1-day share price return of 9.08% and a year to date share price return of 120.63%. The 1-year total shareholder return of 153.30% points to...

Stifel Financial (SF) drew investor attention after its latest market close at $80.96, with recent returns reflecting a mix of short-term weakness and longer-term gains over the past month and the past three months. See our latest analysis for Stifel Financial. Over the past year, Stifel Financial has seen its share price return soften year to date, while its 90 day share price return of 11.53% and 1 year total shareholder return of 8.07% suggest that momentum has been steadier over a longer...

In August 2026, CMC Microsystems announced a memorandum of understanding with IonQ to integrate IonQ’s trapped-ion quantum systems into Canada’s FABrIC Quantum Computing Sandbox, making IonQ a listed cloud quantum provider for Canadian academics and small-to-medium enterprises under a non-binding collaboration framework. This move embeds IonQ within a Canadian government-backed quantum and semiconductor ecosystem, potentially broadening institutional adoption while leaving open how far the...

H World Group Limited recently reported its second-quarter and first-half 2026 results, raised full-year 2026 revenue growth guidance to 4%–8% versus 2025, and approved an ordinary cash dividend of about US$275 million, equal to US$0.087 per ordinary share or US$0.87 per ADS, payable to holders on record as of September 8, 2026. By combining a higher revenue outlook with a sizable cash distribution under its 2026 Shareholder Return Plan, the company is signaling confidence in its current...

Why Opendoor Technologies just tapped the bond market Opendoor Technologies (OPEN) has completed a US$650 million zero coupon convertible note offering that runs to August 2030. This financing move directly touches the company’s capital structure, dilution risk, and liquidity profile for shareholders. See our latest analysis for Opendoor Technologies. For context, Opendoor Technologies’ share price is US$3.53 after a 1-day share price return of 1.73%. The stock is down 7.95% over 30 days and...

Recent concerns shaping sentiment on ADT stock Recent analysis of ADT (ADT) has focused on flat sales over the past five years, rising capital intensity, and below average returns on capital. Shrinking free cash flow margins have also weighed on sentiment. See our latest analysis for ADT. At a share price of US$7.38, ADT has had a mixed run, with the 30 day share price return of 4.83% and 90 day share price return of 5.88% set against a year to date share price decline of 7.87% and a 1 year...

Braze (BRZE) has drawn fresh investor attention after announcing that Pearce Dolan will join as Chief Product Officer on August 24, 2026, with a focus on AI-driven customer engagement products. See our latest analysis for Braze. Braze shares have rallied with a 42.74% 1 month share price return and 27.56% 3 month share price return, yet the year to date share price return is still down 4.58% while the 1 year total shareholder return is 15.49%. This suggests momentum has picked up recently...

Krystal Biotech stock performance snapshot Krystal Biotech (KRYS) has attracted fresh attention after recent share price gains, with the stock closing at $346.58 on 19 August 2026. Investors are weighing these moves against its recent return profile and fundamentals. Over the past month the stock shows a 3.4% return, with about 15.7% in the past 3 months and 40.4% year to date. Its 1 year total return is 130.3%, while the 3 year figure is approximately 1.7 times and the 5 year total return is...

Oruka Therapeutics (ORKA) has filed a universal shelf registration for up to US$1 billion in common and preferred stock, depositary shares and warrants. This filing gives the company flexibility to raise capital when needed. See our latest analysis for Oruka Therapeutics. Oruka Therapeutics shares trade at US$107.96 after a 78.12% 90 day share price return and a very large 1 year total shareholder return, with recent gains pointing to strong momentum despite a softer 7 day share price return...